Multicenter, randomized, double-blind, placebo-controlled, parallel-group trial of liatermin (r-metHuGDNF) administered by bilateral intraputaminal (IPu) infusion to subjects with idiopathic Parkinson's Disease
Phase of Trial: Phase I
Latest Information Update: 11 Jun 2012
At a glance
- Drugs Liatermin (Primary)
- Indications Parkinson's disease
- Focus Therapeutic Use
- 11 Nov 2005 New trial record.